12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Other News

NovImmune hematology news

The NovImmune-led FIGHT HLH consortium received €6 million ($7.8 million) from the EU's Seventh Framework Program (FP7) to develop the company's...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >